CB44 expression and modulation on human neuroblastoma tumours and cell lines

European Journal of Cancer

Volumn 31, Issue 4, 1995, Pages 471-475

  Gross, N ^a   Beck, D ^a   Beretta, C ^a   Jackson, D ^b   Perruisseau, G ^a  

^a EPFL   (Switzerland)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

CD44; differentiation; MYCN; neuroblastoma; prognostic marker

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BROXURIDINE; GAMMA INTERFERON; HERMES ANTIGEN; PHORBOL ESTER; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

ANTIGENS, CD44; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CYTOKINES; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMAN; IMMUNOENZYME TECHNIQUES; NEUROBLASTOMA; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0029007188     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00029-I     Document Type: Article

References (32)

1. Natural history of neuroblastoma
2. Neuroblastoma. Clinical applications of molecular parameters
3. Neuroblastoma. Effect of genetic factors on prognosis and treatment
4. Loss of heterozygosity for chromosome 1 or 14 defines subsets of advanced neuroblastomas
5. Activated expression of the MYCN gene in human neuroblastoma and related tumors
6. Enhanced expression of the human gene NMYC consequent to amplification of DNA may contribute to malignant progression of neuroblastoma
7. Association between high levels of expression of the TRK genes and favourable outcome in human neuroblastoma
8. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma
9. Flow cytometric analysis of neuroblastoma. Correlation with histology and clinical outcome
10. CD44—a new prognostic marker for neuroblastoma
11. CD44H expression by human neuroblastoma cells: relation to NMYC amplification and lineage differentiation
12. Monoclonal antibodies against the CD44 (In(Lu)-related P80) and Pgp-1 antigens in man recognize the Hermes class of lymphocytehoming receptors
13. Adhesion molecules controlling lymphocyte migration
14. A human lymphocyte homing receptor, the Hermes antigen is related to cartilage proteoglycan core and link proteins
15. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
16. CD44 splice variants confer metastatic behaviour in rats: homologous sequences are expressed in human tumor cell lines
17. Significance of CD44 gene products for cancer diagnosis and disease evaluation
18. CD44 and cancer screening
19. Monoclonal antibody to a human brain-granulocyte T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat
20. Differentiation related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants
21. Immunochemical detection of neuroblastoma cells infiltrating bone marrow samples
22. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages
23. In vitro modulation and relationship between MYCN and HLA class 1 RNA steady-state levels in human neuroblastoma cells
24. Coordinate changes in neuronal phenotype and surface expression in human neuroblastoma cell variants
25. Altered growth and phenotype in clonal NMYC transfectants of the SK-N-SH neuroblastoma cell line
26. Expression of CD44R1 adhesion molecule in colon carcinoma metastases
27. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44
28. Epidermal growth factor responsiveness of a new neuroblastoma cell line
29. Expression of leukocyte adhesion molecules on 66 clinical neuroblastoma specimens
30. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning
31. Expression of CD44 is repressed in neuroblastoma cells